ebook Munafa Stock Market Course + Intraday & FNO calls  

       

CRSP announcements Crispr Therapeutics Ag announcements and dividends declared NASDAQ

Crispr Therapeutics Ag Complete list of announcements declared & dividend announcements by Crispr Therapeutics Ag CRSP

Crispr Therapeutics Ag CRSP listed on NASDAQ and deals in Health Care Biotechnology Biological Products No Diagnostic Substances

Announcements and dividends declared by Crispr Therapeutics Ag CRSP

CRISPR Therapeutics Enters 'Second Phase' as CASGEVY Momentum Builds, Pipeline Data Looms
3 Biotech Stocks That Could Benefit from the Patent CliffCRISPR Therapeutics (NASDAQ:CRSP) Chief Executive Officer Sam Kulkarni said the company is entering a “second phase” as it moves beyond the initial launch of CASGEVY and prepares for data
Announcement as on 16 May 2026

CRISPR Therapeutics Announces Pricing Of 0 Mln Of Convertible Senior Notes Offering
(RTTNews) - CRISPR Therapeutics AG (CRSP), Wednesday announced the pricing of 0 million of its convertible senior notes due 2031 in a private offering to persons reasonably believed to be qualified institutional buyers.
Announcement as on 11 March 2026

CRISPR Therapeutics Plans 0 Mln Convertible Senior Notes Offering
(RTTNews) - CRISPR Therapeutics AG (CRSP), on Tuesday said it intends to offer 0 million aggregate principal amount of convertible senior notes due 2031 in a private placement.
Announcement as on 10 March 2026

CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows
CRISPR Therapeutics AG (NASDAQ: CRSP) stock is up more than 12% after the gene editing pioneer reported its Q4 2025 earnings on Feb. 13. At first glance, that may seem contradictory. The company posted a larger net loss than forecast, and revenue came in a
Announcement as on 19 February 2026

Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026?
Key PointsCRISPR has incurred nearly 0 million in losses over the past four quarters.
Announcement as on 19 December 2025

Announcements by Crispr Therapeutics Ag first page | Next page |

CRSP Crispr Therapeutics Ag current price & indicator signals

Moving Averages for Crispr Therapeutics Ag

  • 5Day Average: 53.82
  • 12Day Average: 52.19
  • 20Day Average: 52.97
  • 50Day Average: 52.79
  • 100Day Average: 52.25
  • 150Day Average: 53.11
  • 200Day Average: 55.58

CRSP Indicators & signals

Indicator MACD (12,26,9)

52.93, 52.57, 0.11
Indicator MACD is in positive zone

Indicator ADX (14)

23.81, 22.89, 14.08
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 56
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of CRSP Crispr Therapeutics Ag are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
24 Wed Jun 2026 53.55 53.35 to 55.48 -0.81% 1.12 times
23 Tue Jun 2026 53.99 52.59 to 56.06 -0.68% 0.63 times
22 Mon Jun 2026 54.36 54.08 to 56.08 0.5% 0.9 times
18 Thu Jun 2026 54.09 53.02 to 55.79 1.88% 1.54 times
17 Wed Jun 2026 53.09 51.64 to 55.10 2.04% 1.66 times
16 Tue Jun 2026 52.03 51.28 to 53.27 -1.1% 0.51 times
15 Mon Jun 2026 52.61 50.58 to 53.27 5.64% 0.83 times
12 Fri Jun 2026 49.80 49.71 to 51.25 -0.86% 0.91 times
11 Thu Jun 2026 50.23 49.02 to 51.14 1.6% 1.2 times
10 Wed Jun 2026 49.44 49.41 to 52.45 -3.96% 1.11 times
09 Tue Jun 2026 51.48 49.58 to 53.09 -0.23% 0.71 times
08 Mon Jun 2026 51.60 51.09 to 52.90 -0.44% 0.9 times

Videos related to: CRSP announcements Crispr Therapeutics Ag announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

CRSP announcements Crispr Therapeutics Ag announcements and dividends declared NASDAQ

 

Back to top